LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 17.28 | 27.76 | 1157 | 838 | 1.3795 | 1.1352 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 18.98 | 27.76 | 777 | 941 | 0.8256 | 0.9260 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 18.98 | 27.76 | 864 | 941 | 0.9180 | 0.9666 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 18.98 | 27.76 | 47 | 941 | 0.0499 | 0.1092 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 18.98 | 27.76 | 1200 | 941 | 1.2750 | 1.0979 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 20.68 | 27.76 | 804 | 1119 | 0.7185 | 0.8798 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 20.68 | 27.76 | 846 | 1119 | 0.7560 | 0.8978 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 20.68 | 27.76 | 58 | 1119 | 0.0518 | 0.1482 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 20.68 | 27.76 | 1157 | 1119 | 1.0340 | 1.0126 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 22.39 | 27.76 | 753 | 1305 | 0.5767 | 0.8114 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 22.39 | 27.76 | 787 | 1305 | 0.6027 | 0.8258 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 22.39 | 27.76 | 68 | 1305 | 0.0521 | 0.1750 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 22.39 | 27.76 | 1167 | 1305 | 0.8938 | 0.9600 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.09 | 27.76 | 808 | 1461 | 0.5528 | 0.8031 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.09 | 27.76 | 840 | 1461 | 0.5747 | 0.8154 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.09 | 27.76 | 70 | 1461 | 0.0479 | 0.1756 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.09 | 27.76 | 1069 | 1461 | 0.7314 | 0.8935 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 25.79 | 27.76 | 820 | 1605 | 0.5109 | 0.7832 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 25.79 | 27.76 | 841 | 1605 | 0.5239 | 0.7909 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 25.79 | 27.76 | 84 | 1605 | 0.0523 | 0.2082 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 25.79 | 27.76 | 1136 | 1605 | 0.7077 | 0.8853 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 27.49 | 27.76 | 799 | 1723 | 0.4637 | 0.7579 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 27.49 | 27.76 | 820 | 1723 | 0.4759 | 0.7656 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 27.49 | 27.76 | 77 | 1723 | 0.0447 | 0.1869 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 27.49 | 27.76 | 1114 | 1723 | 0.6465 | 0.8588 | MN20160318_Q01 | N22 |